What does DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE do?

DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE is a specialist medical practice in Merelbeke-Melle. Private Limited, started on 2 September 2021, 1 establishment.

What is the address of DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE?

The registered office of DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE is located at Waterkant 12, 9820 Merelbeke-Melle.

Is DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE still active?

Yes. According to the CBE (18 September 2026) DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE is active, legal situation “Normale toestand”, started on 2 September 2021.

Is DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE registered on Peppol?

Yes, DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE is registered on the Peppol network with ID 0208:0773425144.

Is DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 September 2021; 4 annual accounts filed, latest fiscal year 2025.

How much profit did DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE make in 2025?

DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE posted a profit after taxes of € 282,406 in financial year 2025.

What is the revenue of DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE?

As a small company, DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 372,354.

DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE

Q: What is the enterprise number of DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE?

The enterprise number of DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE is BE0773425144.

Q: When was DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE founded?

DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE was founded on 2 September 2021.

Dossier DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE, printed on 18 September 2026 from databakkes.be/en/0773425144/dokters-van-geyt-de-smet-geriatrie-endocrinologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE from Merelbeke-Melle, company number BE0773425144, closed financial year 2025 with a result of € 282,406 after tax. For that financial year DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE recorded a gross margin of € 372,354 and equity of € 651,406. Compared with financial year 2024, the result moved from € 270,070 to € 282,406. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 28, 2026.

What it is worth Growing

€ 651,406

▲ 77% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 282,406

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 381,343

▼ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 646,406.

People and assets in 2025

Vehicles and equipment

€ 6,470

▼ 45% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 928

▲ € 914 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 40

▼ € 142,425 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 87,222 Gross margin 2022: € 87,222 First fiscal year in the series	€ 193,049 Gross margin 2023: € 193,049 ▲ 121% vs 2022 (€ 87,222) Favourable step	€ 373,316 Gross margin 2024: € 373,316 ▲ 93% vs 2023 (€ 193,049) Favourable step	€ 372,354 Gross margin 2025: € 372,354 Unchanged (€ 373,316) Unfavourable step
Profit after taxes	€ 47,147 Profit after taxes 2022: € 47,147 First fiscal year in the series	€ 130,276 Profit after taxes 2023: € 130,276 ▲ 176% vs 2022 (€ 47,147) Favourable step	€ 270,070 Profit after taxes 2024: € 270,070 ▲ 107% vs 2023 (€ 130,276) Favourable step	€ 282,406 Profit after taxes 2025: € 282,406 ▲ 5% vs 2024 (€ 270,070) Favourable step	▲ 5%
Equity	€ 50,500 Equity 2022: € 50,500 First fiscal year in the series	€ 179,000 Equity 2023: € 179,000 ▲ 254% vs 2022 (€ 50,500) Favourable step	€ 369,000 Equity 2024: € 369,000 ▲ 106% vs 2023 (€ 179,000) Favourable step	€ 651,406 Equity 2025: € 651,406 ▲ 77% vs 2024 (€ 369,000) Favourable step	▲ 77%
Total debts	€ 39,719 Total debts 2022: € 39,719 First fiscal year in the series	€ 65,476 Total debts 2023: € 65,476 ▲ 65% vs 2022 (€ 39,719) Unfavourable step	€ 243,468 Total debts 2024: € 243,468 ▲ 272% vs 2023 (€ 65,476) Unfavourable step	€ 25,483 Total debts 2025: € 25,483 ▼ 90% vs 2024 (€ 243,468) Favourable step	▼ 90%
Cash	€ 48,254 Cash 2022: € 48,254 First fiscal year in the series	€ 134,860 Cash 2023: € 134,860 ▲ 179% vs 2022 (€ 48,254) Favourable step	€ 410,882 Cash 2024: € 410,882 ▲ 205% vs 2023 (€ 134,860) Favourable step	€ 381,343 Cash 2025: € 381,343 ▼ 7% vs 2024 (€ 410,882) Unfavourable step	▼ 7%
Retained profit	€ 45,500 Retained profit 2022: € 45,500 First fiscal year in the series	€ 174,000 Retained profit 2023: € 174,000 ▲ 282% vs 2022 (€ 45,500) Favourable step	€ 364,000 Retained profit 2024: € 364,000 ▲ 109% vs 2023 (€ 174,000) Favourable step	€ 646,406 Retained profit 2025: € 646,406 ▲ 78% vs 2024 (€ 364,000) Favourable step	▲ 78%
Dividend	€ 1,647 Dividend 2022: € 1,647 First fiscal year in the series	€ 1,776 Dividend 2023: € 1,776 ▲ 8% vs 2022 (€ 1,647) Unchanged	€ 80,070 Dividend 2024: € 80,070 ▲ € 78,294 vs 2023 (€ 1,776) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 80,070) Unchanged	▼ 100%
Balance sheet total	€ 90,219 Balance sheet total 2022: € 90,219 First fiscal year in the series	€ 244,476 Balance sheet total 2023: € 244,476 ▲ 171% vs 2022 (€ 90,219) Unchanged	€ 612,468 Balance sheet total 2024: € 612,468 ▲ 151% vs 2023 (€ 244,476) Unchanged	€ 676,889 Balance sheet total 2025: € 676,889 ▲ 11% vs 2024 (€ 612,468) Unchanged	▲ 11%

Key figures of DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE?

What happened at DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 28, 2026 New annual accounts for financial year 2025: profit of € 282,406 (▲ 5% vs 2024). Source: NBB ↗
Sep 2, 2021 New establishment in Merelbeke-Melle. KBO
Sep 2, 2021 Start of the company according to the CBE. KBO

In short

From € 47,147 profit in 2022 to € 282,406 profit in 2025.

Paid € 253,420 in corporate taxes since 2022.

Best year ever: 2025, with € 282,406 profit.

Paid out € 83,493 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE? We notify you, reason included.

Follow DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Waterkant 12

9820 Merelbeke-Melle

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0773.425.144
VAT number: BE 0773.425.144
Registered office: Waterkant 12, 9820 Merelbeke-Melle
Names & denominations: DOKTERS VAN GEYT – DE SMET GERIATRIE - ENDOCRINOLOGIE · GERENDO
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 September 2021
Peppol: Active · Active since 30 Jan 2025
Contact: [email protected] 0479718448
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗